Literature DB >> 24049732

Differential colonization with segmented filamentous bacteria and Lactobacillus murinus do not drive divergent development of diet-induced obesity in C57BL/6 mice.

Isaac T W Harley1, Daniel A Giles, Paul T Pfluger, Stacey L Burgess, Stephanie Walters, Jazzminn Hembree, Christine Raver, Cheryl L Rewerts, Jordan Downey, Leah M Flick, Traci E Stankiewicz, Jaclyn W McAlees, Marsha Wills-Karp, R Balfour Sartor, Senad Divanovic, Matthias H Tschöp, Christopher L Karp.   

Abstract

Alterations in the gut microbiota have been proposed to modify the development and maintenance of obesity and its sequelae. Definition of underlying mechanisms has lagged, although the ability of commensal gut microbes to drive pathways involved in inflammation and metabolism has generated compelling, testable hypotheses. We studied C57BL/6 mice from two vendors that differ in their obesogenic response and in their colonization by specific members of the gut microbiota having well-described roles in regulating gut immune responses. We confirmed the presence of robust differences in weight gain in mice from these different vendors during high fat diet stress. However, neither specific, highly divergent members of the gut microbiota (Lactobacillus murinus, segmented filamentous bacteria) nor the horizontally transmissible gut microbiota were found to be responsible. Constitutive differences in locomotor activity were observed, however. These data underscore the importance of selecting appropriate controls in this widely used model of human obesity.

Entities:  

Keywords:  Inflammation; Metabolism; Microbiome; Nicotinamide nucleotide transhydrogenase; Obesity

Year:  2013        PMID: 24049732      PMCID: PMC3773832          DOI: 10.1016/j.molmet.2013.04.004

Source DB:  PubMed          Journal:  Mol Metab        ISSN: 2212-8778            Impact factor:   7.422


  57 in total

1.  Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion.

Authors:  Helen Freeman; Kenju Shimomura; Emma Horner; Roger D Cox; Frances M Ashcroft
Journal:  Cell Metab       Date:  2006-01       Impact factor: 27.287

2.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

Review 3.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

4.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Intranasal bacteria induce Th1 but not Treg or Th2.

Authors:  M Costalonga; P P Cleary; L A Fischer; Z Zhao
Journal:  Mucosal Immunol       Date:  2008-10-08       Impact factor: 7.313

7.  Diet-induced obesity in two C57BL/6 substrains with intact or mutant nicotinamide nucleotide transhydrogenase (Nnt) gene.

Authors:  Anthony Nicholson; Peter C Reifsnyder; Rachel D Malcolm; Charlotte A Lucas; Grant R MacGregor; Weidong Zhang; Edward H Leiter
Journal:  Obesity (Silver Spring)       Date:  2010-01-07       Impact factor: 5.002

8.  Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome.

Authors:  Peter J Turnbaugh; Fredrik Bäckhed; Lucinda Fulton; Jeffrey I Gordon
Journal:  Cell Host Microbe       Date:  2008-04-17       Impact factor: 21.023

9.  Lymphotoxin regulates commensal responses to enable diet-induced obesity.

Authors:  Vaibhav Upadhyay; Valeriy Poroyko; Tae-jin Kim; Suzanne Devkota; Sherry Fu; Donald Liu; Alexei V Tumanov; Ekaterina P Koroleva; Liufu Deng; Cathryn Nagler; Eugene B Chang; Hong Tang; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2012-08-26       Impact factor: 25.606

10.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

View more
  14 in total

1.  High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine.

Authors:  Julie Tomas; Céline Mulet; Azadeh Saffarian; Jean-Baptiste Cavin; Robert Ducroc; Béatrice Regnault; Chek Kun Tan; Kalina Duszka; Rémy Burcelin; Walter Wahli; Philippe J Sansonetti; Thierry Pédron
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-16       Impact factor: 11.205

2.  Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome.

Authors:  Siegfried Ussar; Nicholas W Griffin; Olivier Bezy; Shiho Fujisaka; Sara Vienberg; Samir Softic; Luxue Deng; Lynn Bry; Jeffrey I Gordon; C Ronald Kahn
Journal:  Cell Metab       Date:  2015-08-20       Impact factor: 27.287

3.  High fat feeding unmasks variable insulin responses in male C57BL/6 mouse substrains.

Authors:  Rebecca L Hull; Joshua R Willard; Matthias D Struck; Breanne M Barrow; Gurkirat S Brar; Sofianos Andrikopoulos; Sakeneh Zraika
Journal:  J Endocrinol       Date:  2017-01-30       Impact factor: 4.286

4.  Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori.

Authors:  Paul S Hoffman; Alexandra M Bruce; Igor Olekhnovich; Cirle A Warren; Stacey L Burgess; Raquel Hontecillas; Monica Viladomiu; Josep Bassaganya-Riera; Richard L Guerrant; Timothy L Macdonald
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

5.  Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance.

Authors:  Artur Galimov; Angelika Hartung; Roman Trepp; Alexander Mader; Martin Flück; Axel Linke; Matthias Blüher; Emanuel Christ; Jan Krützfeldt
Journal:  J Mol Med (Berl)       Date:  2015-07-23       Impact factor: 4.599

6.  Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota.

Authors:  P Carasi; S M Racedo; C Jacquot; D E Romanin; M A Serradell; M C Urdaci
Journal:  J Immunol Res       Date:  2015-02-24       Impact factor: 4.818

Review 7.  Attention to Background Strain Is Essential for Metabolic Research: C57BL/6 and the International Knockout Mouse Consortium.

Authors:  Danielle A Fontaine; Dawn Belt Davis
Journal:  Diabetes       Date:  2016-01       Impact factor: 9.461

8.  Distinct Tlr4-expressing cell compartments control neutrophilic and eosinophilic airway inflammation.

Authors:  J W McAlees; G S Whitehead; I T W Harley; M Cappelletti; C L Rewerts; A M Holdcroft; S Divanovic; M Wills-Karp; F D Finkelman; C L Karp; D N Cook
Journal:  Mucosal Immunol       Date:  2014-12-03       Impact factor: 7.313

Review 9.  Talking microbes: When gut bacteria interact with diet and host organs.

Authors:  Patrice D Cani; Amandine Everard
Journal:  Mol Nutr Food Res       Date:  2015-08-26       Impact factor: 5.914

10.  A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes.

Authors:  Jacqueline H Parilla; Joshua R Willard; Breanne M Barrow; Sakeneh Zraika
Journal:  J Diabetes Res       Date:  2018-04-30       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.